Home
Conditions
Yellow Fever

Clinical trial condition

Yellow Fever

Explore clinical trials studying Yellow Fever. Study availability and eligibility vary by location and protocol.

37 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Yellow Fever trial results

Recruiting

A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population

NCT07103148

Conditions: Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +8 more
Locations: Investigational Site Number : 3400001 San Pedro Sula, Honduras

Investigational Site Number : 3400005 San Pedro Sula, Cortes, Honduras

Investigational Site Number : 3400002 Tegucigalpa, Honduras

Investigational Site Number : 3400003 Tegucigalpa, Honduras

View all 13 locations

View Trial Details

Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

NCT07358910

Conditions: Adenophorea Infections, Adenoviridae Infections, Adenovirus, +163 more
Locations: Institut Pasteur du Cambodge Phnom Penh, Cambodia

View Trial Details

Recruiting

Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination

NCT05859490

Conditions: Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +8 more
Locations: Oregon Health & Science University Portland, Oregon, United States

View Trial Details

Not Yet Recruiting

Baseline Assessment of Skin Resident Memory T Cells in Healthy Unvaccinated Participants

NCT07636551

Conditions: Arbovirus Infections, Biopsy/Methods, Flaviviridae Infections, +9 more
Locations: Clinical Trial Site of the Institute of Tropical Medicine Antwerp, Belgium

View Trial Details

Not Yet Recruiting

Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months

NCT06815835

Conditions: Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +14 more
Locations: Icddr,B Dhaka, Bangladesh

View Trial Details

Not Yet Recruiting

Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination

NCT05450770

Conditions: Arbovirus Infections, Blood-Borne Infections, Communicable Diseases, +18 more
Locations: Not specified

View Trial Details

Completed

A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults

NCT06998004

Conditions: Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +10 more
Locations: Centre for the Evaluation of Vaccination (CEV) Antwerp, Belgium

University Hospital Ghent - Centrum voor Vaccinologie (CEVAC) Ghent, Belgium

View Trial Details

Completed

A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers

NCT02743455

Conditions: Arbovirus Infections, Body Temperature Changes, Fever, +12 more
Locations: University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States

Saint Louis University Center for Vaccine Development St Louis, Missouri, United States

View Trial Details

Completed

Phase 3 Single Arm, Open Study on vYF in Adults

NCT07222059

Conditions: Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +7 more
Locations: Investigational Site Number : 3920001 Takatsuki, Osaka, Japan

Investigational Site Number : 3920002 Chūō, Tokyo, Japan

Investigational Site Number : 3920003 Shinjuku-ku, Tokyo, Japan

Investigational Site Number : 3920004 Taitō City, Tokyo, Japan

View Trial Details

Completed

Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults

NCT07002060

Conditions: Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +8 more
Locations: The Hope Clinic of Emory University- Site Number : 8400006 Decatur, Georgia, United States

Velocity Clinical Research-New Orleans- Site Number : 8400004 New Orleans, Louisiana, United States

Johns Hopkins Bloomberg School of Public Health- Site Number : 8400009 Baltimore, Maryland, United States

Saint Louis University Center for Vaccine Development- Site Number : 8400001 St Louis, Missouri, United States

View Trial Details

Yellow Fever

Yellow Fever trial results

Related conditions